Pasithea Therapeutics Correlations

KTTA Stock  USD 0.71  0.01  1.39%   
The current 90-days correlation between Pasithea Therapeutics and Virax Biolabs Group is -0.11 (i.e., Good diversification). The correlation of Pasithea Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Pasithea Therapeutics Correlation With Market

Significant diversification

The correlation between Pasithea Therapeutics Corp and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and DJI in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving together with Pasithea Stock

  0.61KO Coca Cola Earnings Call TodayPairCorr

Moving against Pasithea Stock

  0.86KB KB Financial GroupPairCorr
  0.81SHG Shinhan Financial Earnings Call This WeekPairCorr
  0.77WF Woori Financial Group Earnings Call TomorrowPairCorr
  0.74KMDA KamadaPairCorr
  0.73AVAL Grupo AvalPairCorr
  0.66PFE Pfizer IncPairCorr
  0.59FNMFO Federal National Mortgage Earnings Call This WeekPairCorr
  0.54BAC-PL Bank of AmericaPairCorr
  0.49NKTR Nektar TherapeuticsPairCorr
  0.47EVGN EvogenePairCorr
  0.47CGEN CompugenPairCorr
  0.45RCUS Arcus BiosciencesPairCorr
  0.94DIS Walt DisneyPairCorr
  0.91MSFT Microsoft Aggressive PushPairCorr
  0.9CSCO Cisco SystemsPairCorr
  0.9IBM International Business Earnings Call TomorrowPairCorr
  0.87AXP American ExpressPairCorr
  0.83AA Alcoa CorpPairCorr
  0.71CVX Chevron CorpPairCorr
  0.63INTC Intel Earnings Call This WeekPairCorr
  0.45HD Home DepotPairCorr
  0.4T ATT Inc Earnings Call TomorrowPairCorr
  0.34WFC-PL Wells FargoPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
REVBVRAX
REVBMNOV
VRAXMNOV
KPRXMNOV
KPRXVRAX
KZRNTRBW
  
High negative correlations   
MNOVNTRBW
REVBNTRBW
KZRREVB
KZRVRAX
VRAXNTRBW
KPRXNTRBW

Risk-Adjusted Indicators

There is a big difference between Pasithea Stock performing well and Pasithea Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pasithea Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NTRBW  12.39  2.78  0.15  23.35  9.44 
 27.62 
 152.46 
ZIVO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MNOV  1.77 (0.18) 0.00 (0.49) 0.00 
 3.36 
 11.32 
ELYM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
VRAX  3.09  0.00  0.00  0.12  0.00 
 5.75 
 15.20 
BWV  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
REVB  4.74 (1.18) 0.00 (3.96) 0.00 
 9.33 
 61.31 
HILS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
KPRX  2.93  0.06  0.00  0.26  3.76 
 5.00 
 55.05 
KZR  2.60 (0.02)(0.01) 0.12  3.48 
 5.17 
 16.72 

Pasithea Therapeutics Corporate Management